Evidence map›Paper›PMID 29483611›Full record

ArticleScientific reports2018

Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X.

Marta Arpone, Emma K Baker, Lesley Bretherton, Minh Bui, Xin Li, Simon Whitaker, Cheryl Dissanayake, Jonathan Cohen, Chriselle Hickerton, Carolyn Rogers and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Significantly ElevatedInternational journal of molecular sciences · 2019
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Marta ArponeFaculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia. marta.arpone@mcri.edu.au.
Emma K BakerCyto-Molecular Diagnostics Research, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Lesley BrethertonFaculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
Minh BuiCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Xin LiCyto-Molecular Diagnostics Research, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Simon WhitakerSchool of Human and Health Science, University of Huddersfield, Queensgate, Huddersfield, United Kingdom.
Cheryl DissanayakeOlga Tennison Autism Research Centre, La Trobe University, Melbourne, VIC, Australia.
Jonathan CohenFragile X Alliance Inc, North Caulfield, VIC, Australia and Centre for Developmental Disability Health Victoria, Monash University, Dandenong, VIC, Australia.
Chriselle HickertonCyto-Molecular Diagnostics Research, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Carolyn RogersGenetics of Learning Disability Service (GOLD service), Hunter Genetics, Newcastle, NSW, Australia.
Mike FieldGenetics of Learning Disability Service (GOLD service), Hunter Genetics, Newcastle, NSW, Australia.
Justine ElliottVictorian Clinical Genetics Services and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Solange M AliagaFaculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
Ling LingCyto-Molecular Diagnostics Research, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
David FrancisVictorian Clinical Genetics Services and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Stephen J C HearpsChild Neuropsychology, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Matthew F HunterMonash Genetics, Monash Health, Melbourne, VIC, Australia and Department of Paediatrics, Monash University, Melbourne, VIC, Australia.
David J AmorFaculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
David E GodlerFaculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
Murdoch Children's Research Institute · AUUniversity of Melbourne · AUHunter Genetics · AULa Trobe University · AUMonash Health · AUMonash University · AURoyal Children's Hospital · AUUniversity of Chile · CLUniversity of Huddersfield · GBVictorian Clinical Genetics Services · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased intragenic DNA methylation of the Fragile X Related Epigenetic Element 2 (FREE2) in blood has been correlated with lower intellectual functioning in females with fragile X syndrome (FXS). This study explored these relationships in a paediatric cohort of males with FXS using Buccal Epithelial Cells (BEC). BEC were collected from 25 males with FXS, aged 3 to 17 years and 19 age-matched male controls without FXS. Methylation of 9 CpG sites within the FREE2 region was examined using the EpiTYPER approach. Full Scale IQ (FSIQ) scores of males with FXS were corrected for floor effect using the Whitaker and Gordon (WG) extrapolation method. Compared to controls, children with FXS had significant higher methylation levels for all CpG sites examined (p < 3.3 × 10

Indexed as

AdolescentChildChild, PreschoolCpG IslandsDNA MethylationEpigenesis, GeneticEpithelial CellsFragile X Messenger Ribonucleoprotein 1HumansIntronsMaleFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID29483611
PMCPMC5827525
OpenAlexW2807166892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.